Published February, 2013
By Gary J. Schiller
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

---

Published January, 2013
By Patrick Y Wen, David A. Reardon, Andrew D. Norden and Patrick C. Y. Wen
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life.

---

Published December, 2012
By Brian J. Bolwell
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Leading transplant physicians critically review and interpret twenty-one key clinical challenges in bone marrow/hematopoietic cell transplantation, and offer their best personal recommendations for treatment.

---

Published October, 2012
By Christopher G. Willett and Brian G. Czito
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Rectal Cancer: International Perspectives on Multimodality Management is a timely analysis of the diagnosis, staging, pathology, and therapy of cancer of the rectum.

---

Published September, 2012
By Maurie Markman
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Maurie Markman and a panel of distinguished clinicians and leading clinical investigators comprehensively review the current status of regional antineoplastic drug delivery in the management of malignant disease.

---

Published August, 2012
By Ernest C. Borden
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel lular protein targets are those of greatest potential for further reducing mortality from melanoma.

---

Published August, 2012
By Ronald M. Bukowski and James H. Finke
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction.

---

Published July, 2012
By G. David Roodman
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

This book presents the forefront in the science and clinical management of myeloma bone disease. Coverage begins with sections on clinical presentation, imaging, and biochemical markers and goes on to discuss radiation, surgical, and medical therapies.

---

Published April, 2012
By David J. Stewart
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States.

---

Published December, 2011
By Thomas Gajewski, F. Stephen Hodi and Thomas F. Gajewski
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Although the cause of most malignant melanomas - over-exposure to ultraviolet light - is well known, effective treatment has remained challenging. The past several years have been marked by extraordinary developments in melanoma treatment in the arena of targeted therapeutics.

---